Studies have confirmed that substances having the ability to inhibit angiotensin converting enzymes are the promising targets to lower the blood pressure and its consequent debilitating cardiac aftermaths, like cardiac hypertrophy, oxidative stress, ischemic heart diseases and heart failure [48,49,50]. Here, ACE is linked to coronary artery disorder.